acetylcysteine

Generic: acetylcysteine

Labeler: somerset therapeutics, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name acetylcysteine
Generic Name acetylcysteine
Labeler somerset therapeutics, llc
Dosage Form SOLUTION
Routes
RESPIRATORY (INHALATION)
Active Ingredients

acetylcysteine 200 mg/mL

Manufacturer
Somerset Therapeutics, LLC

Identifiers & Regulatory

Product NDC 70069-019
Product ID 70069-019_ff350155-6226-41a4-aaec-10bae3e73eca
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA219194
Listing Expiration 2026-12-31
Marketing Start 2025-03-04

Pharmacologic Class

Established (EPC)
antidote [epc] antidote for acetaminophen overdose [epc] mucolytic [epc]
Mechanism of Action
reduction activity [moa]
Physiologic Effect
decreased respiratory secretion viscosity [pe] increased glutathione concentration [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70069019
Hyphenated Format 70069-019

Supplemental Identifiers

RxCUI
307718 307719
UPC
0370069018019 0370069019016 0370069020012 0370069020036 0370069019252 0370069018255
UNII
WYQ7N0BPYC
NUI
N0000175429 N0000175961 N0000008867 N0000175960 N0000175776 N0000175547

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acetylcysteine (source: ndc)
Generic Name acetylcysteine (source: ndc)
Application Number ANDA219194 (source: ndc)
Routes
RESPIRATORY (INHALATION)
source: ndc

Resolved Composition

Strengths
  • 200 mg/mL
source: ndc
Packaging
  • 25 VIAL in 1 CARTON (70069-019-25) / 4 mL in 1 VIAL (70069-019-01)
source: ndc

Packages (1)

70069-019-25 25 VIAL in 1 CARTON (70069-019-25) / 4 mL in 1 VIAL (70069-019-01)

Ingredients (1)

acetylcysteine (200 mg/mL)

Linked Drug Pages (1)

Acetylcysteine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["RESPIRATORY (INHALATION)"], "spl_id": "ff350155-6226-41a4-aaec-10bae3e73eca", "openfda": {"nui": ["N0000175429", "N0000175961", "N0000008867", "N0000175960", "N0000175776", "N0000175547"], "upc": ["0370069018019", "0370069019016", "0370069020012", "0370069020036", "0370069019252", "0370069018255"], "unii": ["WYQ7N0BPYC"], "rxcui": ["307718", "307719"], "spl_set_id": ["d50c8ab6-26f8-4669-89d1-c4d26698159a"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Glutathione Concentration [PE]"], "pharm_class_epc": ["Antidote [EPC]", "Antidote for Acetaminophen Overdose [EPC]", "Mucolytic [EPC]"], "pharm_class_moa": ["Reduction Activity [MoA]"], "manufacturer_name": ["Somerset Therapeutics, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 CARTON (70069-019-25)  / 4 mL in 1 VIAL (70069-019-01)", "package_ndc": "70069-019-25", "marketing_start_date": "20250304"}], "brand_name": "Acetylcysteine", "product_id": "70069-019_ff350155-6226-41a4-aaec-10bae3e73eca", "dosage_form": "SOLUTION", "pharm_class": ["Antidote [EPC]", "Antidote for Acetaminophen Overdose [EPC]", "Decreased Respiratory Secretion Viscosity [PE]", "Increased Glutathione Concentration [PE]", "Mucolytic [EPC]", "Reduction Activity [MoA]"], "product_ndc": "70069-019", "generic_name": "Acetylcysteine", "labeler_name": "Somerset Therapeutics, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acetylcysteine", "active_ingredients": [{"name": "ACETYLCYSTEINE", "strength": "200 mg/mL"}], "application_number": "ANDA219194", "marketing_category": "ANDA", "marketing_start_date": "20250304", "listing_expiration_date": "20261231"}